Company
ZECLINICS
|
|
Products and Services
ZeClinics is a biotech Contract Research Organization (CRO) and early-phase biopharmaceutical
(PHARMA) company using zebrafish for safety and efficacy screenings of novel chemical
molecules and target genes. As leading CRISPR-licensed CRO using zebrafish as a model for
drug discovery, its core competencies are CRISPR-mediated genetic disease models, Target
validation, High Throughput Screening (HTS) of novel molecules, we perform toxicity and efficacy assays in several therapeutic areas:
cardiovascular, CNS and oncological, ophthalmology and muscular.
(PHARMA) company using zebrafish for safety and efficacy screenings of novel chemical
molecules and target genes. As leading CRISPR-licensed CRO using zebrafish as a model for
drug discovery, its core competencies are CRISPR-mediated genetic disease models, Target
validation, High Throughput Screening (HTS) of novel molecules, we perform toxicity and efficacy assays in several therapeutic areas:
cardiovascular, CNS and oncological, ophthalmology and muscular.
Company Representative
| Miñana, Rafael Executive | Terriente, Javier Senior Scientist | Calzolari, Simone Technical |